368 related articles for article (PubMed ID: 27217226)
21. Interaction of telomestatin with the telomeric single-strand overhang.
Gomez D; Paterski R; Lemarteleur T; Shin-Ya K; Mergny JL; Riou JF
J Biol Chem; 2004 Oct; 279(40):41487-94. PubMed ID: 15277522
[TBL] [Abstract][Full Text] [Related]
22. Arylsulfanyl groups - Suitable side chains for 5-substituted 1,10-phenanthroline and nickel complexes as G4 ligands and telomerase inhibitors.
Liu W; Wang S; Dotsenko IA; Samoshin VV; Xue L
J Inorg Biochem; 2017 Aug; 173():12-20. PubMed ID: 28476011
[TBL] [Abstract][Full Text] [Related]
23. [G-quadruplex DNA: myth or reality?].
Riou JF; Gomez D; Lemarteleur T; Trentesaux C
Bull Cancer; 2003 Apr; 90(4):305-13. PubMed ID: 12801813
[TBL] [Abstract][Full Text] [Related]
24. Investigating Pharmacological Targeting of G-Quadruplexes in the Human Malaria Parasite.
Anas M; Sharma R; Dhamodharan V; Pradeepkumar PI; Manhas A; Srivastava K; Ahmed S; Kumar N
Biochemistry; 2017 Dec; 56(51):6691-6699. PubMed ID: 29182860
[TBL] [Abstract][Full Text] [Related]
25. Specific binding of telomeric G-quadruplexes by hydrosoluble perylene derivatives inhibits repeat addition processivity of human telomerase.
D'Ambrosio D; Reichenbach P; Micheli E; Alvino A; Franceschin M; Savino M; Lingner J
Biochimie; 2012 Mar; 94(3):854-63. PubMed ID: 22182489
[TBL] [Abstract][Full Text] [Related]
26. Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase.
Lemarteleur T; Gomez D; Paterski R; Mandine E; Mailliet P; Riou JF
Biochem Biophys Res Commun; 2004 Oct; 323(3):802-8. PubMed ID: 15381071
[TBL] [Abstract][Full Text] [Related]
27. Targeting telomerase and telomeres: a click chemistry approach towards highly selective G-quadruplex ligands.
Moorhouse AD; Haider S; Gunaratnam M; Munnur D; Neidle S; Moses JE
Mol Biosyst; 2008 Jun; 4(6):629-42. PubMed ID: 18493662
[TBL] [Abstract][Full Text] [Related]
28. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
[TBL] [Abstract][Full Text] [Related]
29. G-quadruplex stabilizer 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide induces accelerated senescence and inhibits tumorigenic properties in cancer cells.
Huang FC; Chang CC; Lou PJ; Kuo IC; Chien CW; Chen CT; Shieh FY; Chang TC; Lin JJ
Mol Cancer Res; 2008 Jun; 6(6):955-64. PubMed ID: 18515756
[TBL] [Abstract][Full Text] [Related]
30. In vitro assays predictive of telomerase inhibitory effect of G-quadruplex ligands in cell nuclei.
Yaku H; Murashima T; Miyoshi D; Sugimoto N
J Phys Chem B; 2014 Mar; 118(10):2605-14. PubMed ID: 24328194
[TBL] [Abstract][Full Text] [Related]
31. Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes.
Gowan SM; Heald R; Stevens MF; Kelland LR
Mol Pharmacol; 2001 Nov; 60(5):981-8. PubMed ID: 11641426
[TBL] [Abstract][Full Text] [Related]
32. Development of highly predictive 3D-QSAR CoMSIA models for anthraquinone and acridone derivatives as telomerase inhibitors targeting G-quadruplex DNA telomere.
Zambre VP; Murumkar PR; Giridhar R; Yadav MR
J Mol Graph Model; 2010 Sep; 29(2):229-39. PubMed ID: 20691626
[TBL] [Abstract][Full Text] [Related]
33. G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells.
Tahara H; Shin-Ya K; Seimiya H; Yamada H; Tsuruo T; Ide T
Oncogene; 2006 Mar; 25(13):1955-66. PubMed ID: 16302000
[TBL] [Abstract][Full Text] [Related]
34. The design of G-quadruplex ligands as telomerase inhibitors.
Cuesta J; Read MA; Neidle S
Mini Rev Med Chem; 2003 Feb; 3(1):11-21. PubMed ID: 12570851
[TBL] [Abstract][Full Text] [Related]
35. G-quadruplexes as therapeutic targets.
Neidle S; Read MA
Biopolymers; 2000-2001; 56(3):195-208. PubMed ID: 11745111
[TBL] [Abstract][Full Text] [Related]
36. Plasmodium telomeric sequences: structure, stability and quadruplex targeting by small compounds.
De Cian A; Grellier P; Mouray E; Depoix D; Bertrand H; Monchaud D; Teulade-Fichou MP; Mergny JL; Alberti P
Chembiochem; 2008 Nov; 9(16):2730-9. PubMed ID: 18924216
[TBL] [Abstract][Full Text] [Related]
37. G-quadruplex ligand-induced DNA damage response coupled with telomere dysfunction and replication stress in glioma stem cells.
Hasegawa D; Okabe S; Okamoto K; Nakano I; Shin-ya K; Seimiya H
Biochem Biophys Res Commun; 2016 Feb; 471(1):75-81. PubMed ID: 26845351
[TBL] [Abstract][Full Text] [Related]
38. NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA.
Fedoroff OY; Salazar M; Han H; Chemeris VV; Kerwin SM; Hurley LH
Biochemistry; 1998 Sep; 37(36):12367-74. PubMed ID: 9730808
[TBL] [Abstract][Full Text] [Related]
39. Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands.
Jain AK; Bhattacharya S
Bioconjug Chem; 2011 Dec; 22(12):2355-68. PubMed ID: 22074555
[TBL] [Abstract][Full Text] [Related]
40. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
